Acute Kidney Injury Treatment Market

Apr 27, 2026

Summary  AKI continues to be associated with substantial morbidity and mortality, particularly in hospitalized and ICU-based settings where patients often present with severe underlying illness. TERLIVAZ (terlipressin) is the only approved pharmacologic therapy in the broader AKI space, receiving US FDA...

Jan 17, 2025

Acute Kidney Injury (AKI) is a significant medical condition that affects millions of individuals worldwide each year. It is a rapidly progressive condition that requires timely diagnosis and treatment to prevent severe complications or long-term consequences. AKI is particularly prevalent in hospitalized patients,...

Jan 16, 2025

Acute kidney injury is a sudden and severe condition characterized by the rapid loss of kidney function, resulting in the accumulation of waste products in the blood and imbalances in fluids and electrolytes. It is often caused by factors such as severe dehydration, infections, certain medications, or complications...

Jan 16, 2025

Acute Kidney Injury (AKI), also known as acute renal failure, is a sudden loss of kidney function that occurs over a short period of hours to weeks. This condition is primarily characterized by an increase in nitrogen waste products, as indicated by elevated blood urea nitrogen (BUN) and serum creatinine levels. Co...